Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The progression rate of spinocerebellar ataxia type 2 changes with stage of disease

25 Jan 2018

Abstract excerpt

BACKGROUND: Spinocerebellar ataxia type 2 (SCA2) affects several neurological structures, giving rise to multiple symptoms. However, only the natural history of ataxia is well known, as measured during the study duration. We aimed to describe the progression rate of ataxia, by the Scale for the Assessment and Rating of Ataxia (SARA), as well as the progression rate of the overall neurological picture, by the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmune Neurological Disorders and Treatments
Share to Genetic Neurodegenerative Diseases
Share to Glycogen Storage Diseases and Myoclonus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29370806
DOI: 10.1186/s13023-017-0725-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The progression rate of spinocerebellar ataxia type 2 changes with stage of diseasePMID 29370806Read ↗

Modeling disease progression in spinocerebellar ataxiasSemantic proximity Read ↗

Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.Semantic proximity Read ↗

Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.Semantic proximity Read ↗

Progression of biological markers in spinocerebellar ataxia type 3: analysis of longitudinal data from the ESMI cohortSemantic proximity Read ↗

Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia.Semantic proximity Read ↗

The preclinical stage of spinocerebellar ataxias.Semantic proximity Read ↗

CAG Repeat Size Influences the Progression Rate of Spinocerebellar Ataxia Type 3Semantic proximity Read ↗

Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6.Semantic proximity Read ↗

Capturing clinical progression in multisystemic genetic ataxias: lessons from a prospective study of 884 patients with autosomal recessive or early-onset ataxiaSemantic proximity Read ↗

Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study.Semantic proximity Read ↗

Huntington's disease: clinical correlates of disability and progression.Semantic proximity Read ↗

Neurological phenotypes in spinocerebellar ataxia type 2: Role of mitochondrial polymorphism A10398G and other risk factors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.